In an oral glucose tolerance test, Gastaldelli A (Gastaldelli et al., 2016) demonstrated that acute exenatide administration improves hepatic insulin resistance, hepatic glucose uptake and insulin’s antilipolytic effect, decreases endogenous glucose production, adipose insulin resistance and plasma free fatty acid levels. This evidence concerns the gene INS and Insulin resistance.